Abstract NURR1 is an essential transcription factor for the differentiation, maturation, and maintenance of midbrain dopaminergic neurons (DA neurons) as it has been demonstrated using knock-out mice. DA neurons of the substantia nigra pars compacta degenerate in Parkinson's disease (PD) and mutations in the Nurr1 gene have been associated with this human disease. Thus, the study of NURR1 actions in vivo is fundamental to understand the mechanisms of neuron generation and degeneration in the dopaminergic system. Here, we present and discuss findings indicating that NURR1 is a valuable molecular tool for the in vitro generation of DA neurons which could be used for modeling and studying PD in cell culture and in transplantation approaches. Transduction of Nurr1 alone or in combination with other transcription factors such as Foxa2, Ngn2, Ascl1, and Pitx3, induces the generation of DA neurons, which upon transplantation have the capacity to survive and restore motor behavior in animal models of PD. We show that the survival of transplanted neurons is increased when the Nurr1-transduced olfactory bulb stem cells are treated with GDNF. The use of these and other factors with the induced pluripotent stem cell (iPSC)-based technology or the direct reprogramming of astrocytes or fibroblasts into human DA neurons has produced encouraging results for the study of the cellular and molecular mechanisms of neurodegeneration in PD and for the search of new treatments for this disease.
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Introduction
Dysfunctions of the dopaminergic system are implicated in different pathologies such as Parkinson's disease (PD), schizophrenia, and other psychiatric disorders (Bannon et al. 2002; Buervenich et al. 2000; Rojas et al. 2007; Vuillermot et al. 2011; Xu et al. 2002; Zheng et al. 2003) . PD is the second most common neurodegenerative disease, affecting 1-2 % of the people over 65 years old and 3-5 % of the population over 85 years old (Fahn 2003; Lees et al. 2009 ). This disease is mainly characterized by the degeneration of the dopaminergic neurons (DA neurons) in the substantia nigra pars compacta (SNc) (Braak et al. 1995; Hirsch et al. 1988) . As a consequence, many researchers have focused their work on the study of the dopaminergic system and on the generation of DA neurons as a means of using these cells for therapeutic purposes, either to model PD in vitro or for transplantation.
Different transcription factors (TFs) have been identified as critical regulators during midbrain DA neuron development including the forkhead box protein A2 (FOXA2), NURR1, the Pituitary homeobox 3 (PITX3), the achaetescute complex homolog 1 (ASCL1) and Neurogenin 2 (NGN2). The role of these factors is being investigated and the increase of their expression levels in stem cells and progenitors is being used as a means to generate DA neurons in vitro (Andersson et al. 2007; Hong et al. 2014; Kadkhodaei et al. 2009; Lee et al. 2010; Nunes et al. 2003; Park et al. 2006a Park et al. , b, 2008 Smidt et al. 2004; Yi et al. 2014) . Among these factors, this article has focused on critically revising the role of NURR1 in the dopaminergic system and its interactions with the above mentioned TFs and the growth factors glial cell line-derived neurotrophic factor (GDNF) and brain-derived neurotrophic factor (BDNF) during DA neuron generation and differentiation both in vivo and in vitro.
The emergence of new techniques, like the induced pluripotent stem cell (iPSC)-based technology, and the direct reprogramming of astrocytes and fibroblasts into DA neurons, provides an unprecedented tool to obtain human neurons from healthy and diseased donors for in vitro modeling of PD, and a possible source of cells for transplantation in the future. Promising results have been obtained using these new techniques together with the over-expression of Nurr1 (Addis et al. 2011; Caiazzo et al. 2011; Li et al. 2014; Oh et al. 2014; Theka et al. 2013 ). However, further study is required for the optimization of the protocols so as to increase the numbers of DA neurons obtained, and the acquisition and maintenance of their mature and functional phenotype in cell culture models as well as after transplantation.
The Dopaminergic System Types of DA Neurons and Their Projections
The development of the formaldehyde histofluorescence method enabled the study of catecholamine (CA) neurons in the brain during the early 1960s (Falck et al. 1982) . Firstly, noradrenaline (NA) and dopamine were identified in discrete neuronal systems (Carlsson et al. 1962) . After 2 years, twelve groups of CA cells (A1-A12) were described from the medulla oblongata to the hypothalamus (Dahlstroem and Fuxe 1964) . A13-A17 groups, placed in the diencephalon, olfactory bulb (OB), and retina; along with C1-C3 groups (adrenaline-containing cell groups), were identified later (Björklund and Dunnett 2007; Prakash and Wurst 2006) . DA neurons can be divided in different groups depending on the cell body localization. From caudal to rostral regions, we can find: mesencephalic (mes) DA neurons (here also termed midbrain DA neurons) (A8-A10); diencephalic DA neurons (A11-A15); and telencephalic DA neurons (A16-A17), as depicted in Fig. 1 and Table 1 . Ventral midbrain DA neurons are implicated in the control of voluntary movement, body posture and in the modulation of cognitive and emotional/rewarding behaviors. In addition, recent findings suggest that A9 and A10 neurons could regulate adult neurogenesis. These neurons degenerate in PD (Björklund and Dunnett 2007; Freundlieb et al. 2006; Fu et al. 2012; Li et al. 2014; Prakash and Wurst 2006; Yetnikoff et al. 2014) .
Olfactory bulb DA neurons (A16) express L-aromatic amino acid decarboxylase (AADC) and the dopamine transporter (DAT). However, findings about the vesicular monoamine transporter 2 (VMAT2) expression (which is needed for vesicle storage and release) in these neurons are controversial. Vmat2 mRNA was reported in periglomerular neurons (PGNs) in a recent study (Borisovska et al. 2013) , while previous studies could not detect its expression by immunocytochemistry (Peter et al. 1995; Weihe et al. 2006) . Moreover, G-protein-regulated inwardrectifier potassium channel 2 (GIRK2) expression has been detected in dendrites of PGNs in the OB (Schein et al. 1998) . However, calretinin and calbindin are not present in OB DA neurons (Hurtado-Chong et al. 2009; ParrishAungst et al. 2007 ) whereas they are expressed by midbrain DA neurons (Gonzalez-Hernandez and Rodriguez 2000; Vergaño-Vera et al. 2015) .
Interestingly, DA neurons from the OB coexpress dopamine as well as gamma-aminobutyric acid (GABA) and glutamic acid decarboxylase (GAD), an enzyme involved in GABA synthesis. This fact suggests the possibility that these neurons use more than one neurotransmitter (Kiyokage et al. 2010; Kosaka and Kosaka 2011) . The release of GABA has also been reported from midbrain DA neurons (Tritsch et al. 2012) . However, the large majority of these latter DA neurons are not GABAergic (Rodriguez and Gonzalez-Hernandez 1999) .
Nurr1: Expression, Function and Its Relation with The Development and Maintenance of Da Neurons
NURR1 is a TF belonging to the orphan nuclear receptor family 4 (NR4A) whose members are considered to be Immediate early genes. Members of this family share a common structure comprised a weakly conserved aminoterminal A/B region which possesses the activation function-1 transactivation domain, and two highly conserved domains: a DNA-binding domain and a carboxy-terminal ligand-binding domain. The DNA-binding domain can activate transcription when it binds to an NGFI-B response (Björklund and Dunnett 2007; Freundlieb et al. 2006; Fu et al. 2012; Li et al. 2014; Prakash and Wurst 2006; Yetnikoff et al. 2014) . See Table 1 for additional information and references element (NBRE). NURR1 forms heterodimers with retinoid X receptor (RXR) and bind to RXR response element or it can activate transcription as homodimers or monomers. No ligands have been identified for the NR4A receptors and their activity seems to be regulated by ligandindependent mechanisms at the level of gene expression, protein stability, and protein-protein interactions (Díaz-Guerra et al. 2013; Hawk and Abel 2011; Ichinose et al. 1999; Kurakula et al. 2014; Paulsen et al. 1995; Renaud et al. 1995) .
In rodents, the expression of this TF is confined to the nucleus of neurons distributed along the central nervous system (CNS), the highest expression is detected in the substantia nigra (SN), ventral tegmental area (VTA), and retrorubral field of the midbrain and in limbic areas (Backman et al. 1999; Zetterström et al. 1996) . Moreover, NURR1 is also present in the OB, where it appears to be expressed in a synaptic activity-dependent manner (SainoSaito et al. 2004) , temporal cortex, hippocampus, posterior hypothalamus, striatum, subiculum, cerebellum, and habenular nuclei (Saucedo-Cárdenas and Conneely 1996; Xiao et al. 1996) . NURR1 expression has been detected in tyrosine hydroxylase (TH) positive neurons from the SN (96 %), VTA (95 %), retrorubral field (91 %), raphe nuclei (91 %), OB periglomerular neurons (85 %), and central gray of the diencephalon (61 %). Modest NURR1 expression was also found in TH immunoreactive neurons from the paraventricular and periventricular hypothalamic nucleus, while it could not be detected in the noradrenaline neurons of the brainstem. The fact that NURR1 expression is highly confined to OB periglomerular and midbrain DA neurons and that it could not be observed in all CNS catecholaminergic neurons, suggests a possible specific role for this TF in the regulation of DA functions in the OB and midbrain (Backman et al. 1999; Díaz-Guerra et al. 2013 ).
The murine NURR1 starts to be expressed in the CNS around embryonic day (E) 10.5, after FOXA2 and just before PITX3 and TH (E11.5) can be detected. NURR1 expression is reduced in postnatal animals. However, DA neurons continue expressing NURR1 throughout life. This fact indicates that NURR1 may be implicated not only in an early stage of DA neuron differentiation, but also in cell maintenance and acquisition of neurotransmitter identity (Alavian et al. 2014; Kadkhodaei et al. 2009; Kaestner et al. 1994; Law et al. 1992; Le et al. 1999a; SaucedoCárdenas et al. 1998; Smits et al. 2003; Zetterström et al. 1997) . Additionally, it is implicated in the maintenance of neuronal fiber integrity and nuclear-encoded mitochondrial gene expression (Kadkhodaei et al. 2013) . Moreover, this TF prevents mitochondrial impairment, which has been described in PD (Lee et al. 2002; Zhang et al. 2009 ). Furthermore, in microglia and astrocytes NURR1 inhibits neurotoxic mediators showing anti-inflammatory effects, which protects from DA neuronal loss in PD (Saijo et al. 2009 ).
Numerous studies have reported the importance of NURR1 for the survival and differentiation of mesDA progenitor neurons. Studies of Nurr1 deletion showed that Nurr1 knock-out mice have poor motor function and died within the first two days after birth due to milk-suckling difficulty. These mice have a lack of DA neurons in the SN and VTA, while neurons from other regions not involved in motor control such as the OB and hypothalamus were preserved. Moreover, TH as well as other DA markers including aldehyde dehydrogenase 2 (ALDH2) and the receptor tyrosine kinase, c-RET, could not be detected both in SN and VTA. Dopamine was also absent in these regions, and it was absent or practically absent in the striatum (levels decreased by 98 %), while other CAs were not significantly affected (Baffi et al. 1999; Le et al. 1999a; Zetterström et al. 1997) . The lack of NURR1 does not impair the acquisition of a normal ventral localization and neuronal phenotype of the neuroepithelial cells that will generate DA neurons. Nevertheless, NURR1 seems to be essential for the differentiation of these late progenitors into mature DA neurons since in the absence of NURR1 they fail to differentiate into of a fully DA phenotype, as mentioned above. Moreover, in older animals, Nurr1 depletion leads to the degeneration of these progenitor cells, with a loss of Pitx3 expression and an increase in the apoptosis of ventral midbrain neurons (Saucedo-Cárdenas et al. 1997 ).
In contrast, Nurr1-deficient heterozygous mice survive to adulthood and do not show major motor problems (Le et al. 1999a; Saucedo-Cárdenas et al. 1998; Zetterström et al. 1997) . After birth, dopamine levels in the striatum of heterozygous mice are lower than in the wild type (Saucedo-Cárdenas et al. 1998; Zetterström et al. 1997) . However, in the adult, reports regarding the levels of dopamine are controversial as Zetterström et al. (1997) showed a decrease in dopamine both in midbrain and striatum, whereas Le et al. (1999a, b) reported no differences in striatal dopamine (Le et al. 1999a, b; Zetterström et al. 1997 ) that could be explained by the existence of compensatory mechanisms (Calne and Zigmond 1991; Whone et al. 2003) . Dopamine levels have also been measured by other authors in different regions of the Nurr1
?/-brain showing lower levels of dopamine in the whole brain, midbrain, prefrontal cortex, and nucleus accumbens, while no significant differences were found in the striatum, OB or hippocampus. Moreover, heterozygous mice presented increased stress-induced locomotor activity, which is thought to be related to reduced mesolimbic and mesocortical dopamine levels (Eells et al. 2002) . Furthermore, mesDA neurons from Nurr1
?/-mice presented higher vulnerability to the neurotoxin MPTP, which proves the importance of this TF in the maintenance of mature midbrain DA neuron function. Consequently, susceptibility to SN injury may be higher when there is a defect in Nurr1 expression (Le et al. 1999b) .
In other studies, Nurr1 was conditionally removed either at late stages of midbrain DA neuron development or in the adult brain. In maturating DA neurons, Nurr1 deletion caused rapid loss of midbrain DA markers, loss of striatal dopamine and neurodegeneration. Neurons from the SNc were more vulnerable than neurons from the VTA, as it has been described in PD. Moreover, conditional Nurr1 ablation in mature DA neurons gave rise to progressive pathology with impaired motor behavior and dystrophy of dendrites and axons of DA neurons. Transcriptome analysis in these neurons showed that Nurr1 mainly regulates the transcription of the nuclear-encoded mitochondrial genes (involved either in oxidative phosphorylation or mitochondrial ribosome) although it also regulates a battery of genes expressed in DA neurons (as Th and Vmat2). Thus, NURR1 has been shown to sustain high respiratory function in DA neurons. These results are evidences of the importance of this TF for the maintenance of DA neurons and suggest that Nurr1 disruption may contribute to the etiology of PD (Kadkhodaei et al. 2009 (Kadkhodaei et al. , 2013 .
The role of NURR1 in the specification and maintenance of the mesDA neuron phenotype has been demonstrated with additional studies reporting that NURR1 promotes the acquisition of DA marker expression like TH, DAT, AADC, and VMAT2 (Hermanson et al. 2003; Kim et al. 2003a; Sacchetti et al. 2001; Sakurada et al. 1999; Schimmel et al. 1999) . The regulation of Th gene expression by NURR1 appears to be species-specific. Indeed, in murine cells, NURR1 has been shown to bind to the NBRE site in the Th promoter to regulate Th transcription (Kim et al. 2003a; Sakurada et al. 1999) , however, although it can bind to the human TH promoter, its relation with TH regulation has been controversial (Jin et al. 2006; Romano et al. 2005) . Recently it has been reported that NURR1 represses human TH promoter via SIRT-1 (a class III histone deacetylase) in human neural stem cells (NSCs), but it transactivates this promoter in DA neurons, switching from transcriptional repressor to activator during midbrain DA neuronal development (Kim et al. 2013) . Moreover, Smits et al. (2003) reported that NURR1 expression is required for VMAT2 and DAT induction in mesDA neurons while AADC expression is independent of NURR1 function . Furthermore, BDNF has been identified as another downstream target of NURR1, which may have implications in the maturation of DA neurons (Volpicelli et al. 2007) .
As a result of the important role of NURR1 in the DA system, alterations in the expression of NURR1 and mutations in Nurr1 gene have been related with PD and several psychiatric disorders as manic behavior, schizophrenia and predisposition to cocaine abuse (Bannon et al. 2002; Buervenich et al. 2000; Le et al. 2003; Rojas et al. 2007; Vuillermot et al. 2011; Xu et al. 2002; Zheng et al. 2003) .
Regulation of mesDA Neuron Development
DA neural induction in stem/progenitor cells is determined by Sonic hedgehog (SHH) signaling, which is secreted by ventral midline cells of the neural tube or the floor plate (FP), and the activity of the fibroblast growth factor family member 8 (FGF8), released by the cells of the mid-/hindbrain boundary (MHB) or the so-called isthmic organizer (Hynes et al. 1995a, b; Hynes and Rosenthal 1999) . These two factors are secreted proteins needed for specifying the DA phenotype in the ventral midbrain and forebrain at initial stages of neural development (Ye et al. 1998 ). Other factors implicated in neuronal differentiation and subtype specification are NGN2, ASCL1, and FOXA2. NGN2 and ASCL1 are proneural factors that mediate initial neurogenesis (Kele et al. 2006) and the specification of different neurotransmitter identities (Bertrand et al. 2002) . Neurogenins can also repress glial fate promoting a neuronal fate (Sun et al. 2001; Tomita et al. 2000) . FOXA2 positively regulates Ngn2 expression, and subsequently it regulates Nurr1 and Engrailed 1 (En1) expression in immature neurons. FOXA2 has also been described to cooperate with NURR1 through epigenetic mechanisms to activate the DA phenotype, including Th and Aadc expression. Additionally, at late embryonic stages, it is involved in the maintenance of dopaminergic properties of ventral midbrain neurons. FOXA2 functions have been described to be dependent on its dosage (Ferri et al. 2007; Kittappa et al. 2007; Stott et al. 2013; Yi et al. 2014) .
There are other factors as the engrailed genes (EN1 and EN2), LMX1A and LMX1B involved in early and late development. EN1 and EN2 expression starts at E8 in mice at the isthmic organizer. At this point, these factors maintain and regulate the expression of FGF8 mediating the induction of mesDA neurons. Moreover, in mesDA neurons, between E11.5 and E14 in mice the expression of engrailed genes is needed for neuronal survival (Alavian et al. 2014 ). LMX1A and LMX1B have been identified as key TFs involved in the early specification of ventral midbrain DA neurons. These TFs are also expressed in postmitotic differentiating midbrain DA neurons although their role after the specification of proliferating progenitors is still unknown. Interestingly, LMX1B is needed for a proper autophagic-lysosomal function as well as for the maintenance of the DA nerve terminals and the long-term survival of the midbrain DA neurons (Laguna et al. 2015) .
NURR1 as well as other characterized TFs such as PITX3 are not implicated in the initial specification of multipotent stem cells to become DA neural progenitors but are necessary for progenitor differentiation and the maturation of postmitotic DA neurons (Jacobs et al. 2009a, b; Nunes et al. 2003; Roybon et al. 2008; Simon et al. 2001; Smidt et al. 2004; van den Munckhof et al. 2003; Volpicelli et al. 2012; Wallen and Perlmann 2003; Zetterström et al. 1997) . Both NURR1 and PITX3 are involved in the regulation of gene expression required for neuronal patterning, axon outgrowth, and terminal differentiation (Jacobs et al. 2009a) . PITX3 is expressed after NURR1 expression as it happens with some typical DA markers such as TH and DAT. Indeed, NURR1 has been demonstrated to control PITX3 expression by binding to a non-canonical NBRE consensus sequence promoting its translation (Volpicelli et al. 2012) . Moreover, NURR1 and PITX3 seem to interact with the promoters of NURR1 target genes to generate the DA phenotype through a regulation mediated by co-repressors such as the polypyrimidine tract-binding protein-associated splicing factor and the silencing mediator of retinoic acid and thyroid hormone receptor (Jacobs et al. 2009b) .
Finally, terminal differentiation and maturation of DA neurons require the expression of all the enzymes, receptors and transporters for the synthesis, storage, release and reuptake of dopamine such as TH, AADC, VMAT2, Dopamine class 2 receptor (D2R) and DAT. Furthermore they have to reach, innervate and establish regulated synaptic contacts in their corresponding target areas of the brain (Le Grand et al. 2015; Riddle and Pollock 2003; Smidt et al. 2003; Vergaño-Vera et al. 2015) .
Regulation of Olfactory Bulb DA Neuron Development
Studies dealing with the development of OB DA neurons are scarcer than those for mesDA neurons. Similar to mesDA neurons, OB DA neurons are thought to be initially specified by SHH and FGF8 (Prakash and Wurst 2006) . As mentioned above NURR1 is expressed in PGNs (Backman et al. 1999; Saino-Saito et al. 2004 ). However, its role and influence on DA generation from OB stem cells (OBSCs) is not well understood although recent data from our laboratory suggest that NURR1 induces the generation of mesencephalic-like DA neurons and DA-GABAergic neurons (Fig. 2) through mechanisms possibly involving the regulation of fibroblast growth factor receptor 2 (Fgfr2) (Díaz-Guerra et al. 2013; Vergaño-Vera et al. 2015 ) (see next).
In Vitro Studies Using Nurr1 for The Generation of Da Neurons
As mentioned above, NURR1 plays a crucial role in the differentiation of DA progenitor cells to mature DA neurons and in the survival and maintenance of these neurons. Thus, the regulation of NURR1 expression levels is being explored as a means to generate DA neurons in vitro (Table 2) . These neurons could be used to study the function and mechanisms of action of NURR1 in the DA system, and as a potential source of neurons for both, transplantation in PD and to study mechanisms of degeneration.
Nurr1 Over-Expression in Neural Progenitors and NSCs
A variety of approaches to over-express Nurr1 have been used for the generation of DA neurons in cell culture. However, some research groups reported the generation of immature DA neurons or non-neuronal TH-positive cells when Nurr1 was over-expressed alone (Hong et al. 2014 ; Fig. 2 Model illustrating the role of Nurr1 in the proliferation and differentiation of mouse embryonic OBSCs. Transduction of Nurr1 using a retroviral vector (pRV-Nurr1-EGFP) induces the generation of mature-like mesencephalic dopaminergic neurons and a subpopulation of dopaminergic-GABAergic neurons. In addition to marker expression, dopamine release and c-Fos induction were detected in the cultures indicating that the Nurr1-derived DA neurons acquired functional features. BDNF brain-derived neurotrophic factor, cAMP cyclic adenosine monophosphate, DAT dopamine transporter, EGF epidermal growth factor, FBS fetal bovine serum, FGF-2 fibroblast growth factor 2, GABA gamma-aminobutyric acid, GAD glutamic acid decarboxylase, GDNF glial cell line-derived neurotrophic factor, GIRK2 G-protein-regulated inward-rectifier potassium channel 2, OBSCs olfactory bulb stem cells, PLO polyornithine, pRV-Nurr1-EGFP retroviral particles expressing Nurr1 and enhanced green fluorescent protein, TH tyrosine hydroxylase, VGAT vesicular GABA transporter, VMAT2 vesicular monoamine transporter 2. This model is based on the work by Vergaño-Vera et al. (2015) DA release and uptake DA-specific electrophysiological profiles Restoration of PD motor symptoms in a rodent PD model for 8 weeks Park et al. 2006a; Sakurada et al. 1999; Wagner et al. 1999) . In one of the first reports Sakurada et al. (1999) using adult hippocampal precursors demonstrated that over-expression of Nurr1 in these cells gave rise to induction of TH expression by direct binding of NURR1 to the Th promoter. Nevertheless, it did not seem to affect the expression of other DA markers such as AADC, the protein tyrosine kinase receptor c-RET, PITX3, D2R, or VMAT2, indicating that NURR1 did not stimulate fully neuronal differentiation (Sakurada et al. 1999) . Along the same line, Wagner et al. (1999) over-expressing Nurr1 in a cerebellum-derived immortalized cell line C17.2 could obtain mature DA neurons only when they were co-cultured with ventral mesencephalic type I astrocytes. In subsequent assays, neural progenitor cells (NPCs) isolated from different developmental stages and regions of origin have been differentiated into functional and mature DA neurons in vitro although a proportion of Nurr1-infected neurons in the culture remained immature (Kim et al. 2003b) . These authors were able to obtain Nurr1-derived DA neurons, which showed spontaneous, and potassium-evoked dopamine release and expressed dopaminergic markers as Th, Aadc, DAT, Vmat, and Pitx-3 detected by RT-PCR. Nevertheless, when these cells were grafted in 6-hydroxydopamine-lesioned rats Parkinsonian symptoms could not be restored.
Furthermore, we obtained DA neuronal mature phenotypes in vitro by over-expressing Nurr1 in NSCs (progenitors that have self-renewal and multipotentiality) isolated from the mouse OB (termed OBSCs) (Vergaño-Vera et al. 2015) . Nurr1 over-expression in OBSCs inhibited cell proliferation and gave rise to the generation of immature neurons, which under long-term culture conditions generated mature-like mesDA neurons, and a subpopulation of DA-GABAergic neurons. The mesencephalic-like neurons obtained expressed TH, GIRK2, VMAT2, DAT, calretinin, calbindin, synapsin-I, and synaptic vesicle protein 2 (SV2), while DA-GABAergic neurons presented TH, GAD, GABA and vesicular GABA transporter (VGAT) expression (Fig. 2) . Moreover, c-FOS could be induced in these neurons after exposure to the Dopamine 1 class receptor (D1R) agonist SKF-38393 and dopamine release was detected in basal and KCl-evoked conditions suggesting the functionality of the Nurr1-generated neurons. However, electrophysiological recordings were not performed in these studies and a proportion of the neurons remained immature, as previously found in other studies (Kim et al. 2003b) . From a molecular mechanistic view, the Fgfr2 was accumulated in Nurr1-transduced OBSCs suggesting a novel role for this receptor in the generation of DA neurons (Vergaño-Vera et al. 2015) . When the Nurr1-infected OBSCs (Fig. 3) were transplanted in the lesioned striatum of a mouse model of PD (Pavón et al. 2006 ) the survival of THpositive neurons was relatively low (Fig. 4a, d ). This survival was markedly increased (2.7-3.1 fold) when cultured cells were previously infected with lentiviral particles expressing Gdnf (Fig. 4b-d ). Very few TH-positive cells were detected in vivo after transplanting control cells (without Nurr1 or Gdnf treatment) (data not shown). Thus, GDNF is a critical factor that promotes the in vivo survival of Nurr1-transduced cells. Co-over-Expression of Nurr1 with Other TFS Differences in the mature state of the cells obtained after Nurr1 over-expression in different neural progenitors may be consequence of differences in the developmental stage of the studied cells, the brain region from where the cells were isolated and the composition of culture cell media including the addition of growth factors. In order to overcome the possible problem of generating immature neurons, some authors have tried to co-over-express Nurr1 with other transcription factors such as Ngn2, Pitx3, Foxa2, or Ascl1. An alternative approach has been to reduce and delay the high levels of Nurr1 some days later after its initial over-expression (Park et al. 2012) . 
NURR1 and NGN2
NGN2 belongs to the basic helix-loop-helix (bHLH) family of TFs and it is necessary for the development of midbrain DA neurons in vivo (Andersson et al. 2006; Kele et al. 2006 ) (see before). However, when Ngn2 was co-transduced together with Nurr1 in different neural progenitors the results varied among studies. We co-transduced mouse embryonic OBSCs with Nurr1 and Ngn2 in an attempt to increase the yield and the mature state of the DA neurons. However, the proportion of TH-positive neurons was significantly reduced. Moreover, similar profiles of presynaptic protein expression were observed when DA neurons from Nurr1 and Nurr1 ? Ngn2 cultures were immunostained for Synapsin-I and SV2. Furthermore, when we transduced OBSCs with Nurr1 alone, NURR1 did not induced NGN2 expression, which might indicate that NURR1 effects in OBSCs are independent of NGN2 (Vergaño-Vera et al. 2015) . Park et al. (2006b) using rat embryonic midbrain and NPCs from embryonic cortex, ventral midbrain and lateral ganglionic eminence (LGE) reported a repression in DA markers (Th, DAT, Aadc, and Vmat2) when cells were cotransduced with Nurr1 and Ngn2 (Park et al. 2006b ). Nevertheless, Ngn2 plus Nurr1 co-transduction was reported to increase the production of DA neurons from fetal brain midbrain progenitors (Andersson et al. 2007 ). These authors found that Nurr1 over-expression gave rise to immature cells expressing TH but no other DA markers such as VMAT2. In contrast, cells transduced only with Ngn2 did not generate TH-positive neurons although the total neuronal yield obtained was increased. Only the cotransduction of Nurr1 with Ngn2 generated VMAT2-positive DA neurons (Andersson et al. 2007 ). Furthermore, Park et al. (2008) showed that the action of NGN2 in the differentiation of DA neurons induced by NURR1 in rat and mouse was species-dependent. While Nurr1 over-expression in rat NPCs (from embryonic cortex, ventral midbrain and LGE) caused an efficient TH-positive DA cell generation; in mouse cultures, TH-positive cell yields were low and variable. However, Ngn2 co-expression with Nurr1 in rat cultures repressed the generation of TH-positive cells while in mouse it was highly increased (Park et al. 2008) . In summary, all these results suggest that NGN2 and NURR1 function is dependent of cell-context and animal species.
NURR1 and ASCL1
ASCL1 is another transcription factor belonging to the bHLH family that has been used to increase the maturation and/or DA neuron yield from stem and progenitor cells (Park et al. 2006a, b; Shim et al. 2007 ). Shim et al. (2007) showed that whereas exogenous expression of Nurr1 in progenitors from the subventricular zone (SVZ) and white matter of adult rodents generated functional mature neurons in vitro, the co-transduction of Ascl1 and treatment with BDNF and neurotrophin-3 increased Nurr1-induced DA neuronal yield. Nurr1 and Nurr1-Ascl1 transduced cells were grafted into Parkinsonian rats, where these cells survived, integrated and were able to differentiate in vivo reversing the behavioral deficit of the rodents for 6 weeks after transplantation. The effects observed when co-transduced cells were grafted were higher than those of cells transduced with Nurr1 alone (Shim et al. 2007 ). Interestingly, Park et al. (2006b) reported an improvement in the DA release and uptake in neurons derived from rat NPCs from cortex, ventral midbrain and LGE when Nurr1 was co-transduced with Ascl1. This gave rise to mature and functional neurons, which released DA and expressed presynaptic DA neuron markers. This effect was not the result of a cooperative or synergistic effect of NURR1 and ASCL1 for the expression of genes related with DA release or uptake (Vmat2 and DAT), but it might indicate a possible direct role of ASCL1 in the functional maturation of VMAT2 and DAT. However, ASCL1 did not activate TFs specific of midbrain DA neurons (Nurr1 and Pitx3) indicating that the neurons did not reach a genuine mesencephalic phenotype (Park et al. 2006b ). In addition, cotransduced cells were grafted in Parkinsonian rats where cells survived, differentiated and reversed behavioral deficits of the animals for up to 8 weeks after transplantation (Park et al. 2006a ).
NURR1 and FOXA2
Over-expression of Foxa2, a forkhead transcription factor has also been tested as a means to increase the yield of mature DA neurons following Nurr1 over-expression paradigms (Lee et al. 2010; Yi et al. 2014) . Lee et al. (2010) showed that co-expression of Nurr1 and Foxa2 in cortical progenitors induced not only DAT and VMAT2 expression but also midbrain-specific markers such as endogenous NURR1, WNT-3A, LMX1B, and CORIN; and markers specific of A9 midbrain neurons such as ALHD2, PITX3, and GIRK2. Co-expression of both TFs resulted in a synergistic increase of VMAT2 and DAT levels, and the cells obtained had enhanced DA neuronal function.
Recently, FOXA2 has been shown to function as a coactivator of the Nurr1-induced DA phenotype by epigenetic mechanisms (Yi et al. 2014) . Moreover, DA neurons were efficiently generated from rodent NPCs from different brain regions and human NPCs derived from human embryonic stem cells (ESCs). NPCs from rat embryonic cortex transduced with Nurr1 and Foxa2 were transplanted into Parkinsonian rats where grafts were enriched with Neurotox Res (2016) 30:14-31 25 midbrain-like DA neurons while the number of proliferating cells was reduced. After transplantation, Parkinsonian rats showed a reversion of their motor deficits for at least 8 weeks post-transplantation. Furthermore, co-transduced cells were more resistant to toxic stimuli suggesting a protective role of NURR1 (Lee et al. 2010 ). Over-expression of these two TFs in neighboring glia also protects degenerating midbrain DA neurons by paracrine mechanisms. Thus, midbrain DA neurons from midbrain neuronglia cultures obtained after over-expression of Nurr1 and Foxa2 were more resistant to toxic insult. Furthermore, in vivo midbrain transduction with Nurr1 and Foxa2 viral vectors resulted in protection of midbrain DA neurons and improvement of motor symptoms in a PD mouse model upon 8 weeks after transduction. Notably, the transgene expression was maintained for up to 6 months observing therapeutic and cytoprotective effects after 1 year of gene delivery (Oh et al. 2015) . In sum, the combination of Nurr1 and Foxa2 not only induced the generation and differentiation of DA neurons but also their survival and resistance to toxic insult.
NURR1 and PITX3
PITX3 belongs to the RIEG/PITX homeobox family of TFs. This factor has been used alone or along with Nurr1 in murine and human ESC and NSC cultures for the generation of midbrain DA neurons (Martinat et al. 2006; O'Keeffe et al. 2008) . Using NPCs derived from ESCs, PITX3 has been shown to bind within Ngn2 and betatubulin III genes, which suggests a possible regulation of these genes by this TF (Hong et al. 2014 ). However, Pitx3 over-expression alone, neither in ESCs nor in NPCs, is enough to induce the formation of mature midbrain DA neurons, although it might enforce the expression of some DA markers as ALDH2 (Chung et al. 2005) . In contrast, NURR1 and PITX3 can synergistically promote the maturation to midbrain DA neurons generated from ESCs. Martinat et al. (2006) showed that late DA markers, as DAT and the tyrosine-related protein1 (TYRP1), were synergistically induced by both TFs in ESC cultures, whereas this effect was not observed in early markers such as TH and ALDH2 that appeared to be induced by NURR1 and PITX3 alone, respectively. The co-transduced mouse and human ESCs were differentiated to NPCs and grafted into a mice PD model reducing behavioral symptoms for up to 6 weeks although at 8 weeks, teratoma formation was observed in some animals grafted with mouse cells. Interestingly, this effect was not observed in animals grafted with NPCs derived from human ESCs. Moreover, GABAergic and serotonergic neurons were not induced by Nurr1 and Pitx3 co-expression, indicative that the DA neurons had a mesencephalic phenotype (Martinat et al. 2006 ).
Nurr1 Over-Expression in ESCS, iPSCs and Fibroblasts
Gain-of-function studies have shown the induction of DA neuron generation from mouse and human ESCs (Chung et al. 2002; Hong et al. 2014; Kim et al. 2002; Martinat et al. 2006) . Chung et al. (2002) reported a fourfold to fivefold increase in the number of DA neurons in NURR1 expressing clones as well as an up-regulation of DA markers. The TH neurons generated resembled midbrain DA neurons as they expressed AADC, DAT and calretinin and they were negative for GABA and serotonin. Moreover, neurons obtained presented synaptic functionality as they were able to produce and release DA in response to depolarization (Chung et al. 2002) . In the study by the group of Ron McKay, high numbers of DA neurons were obtained after Nurr1 over-expression in mouse ESCs. These neurons were successfully grafted and ameliorated motor symptoms in a rodent model of PD for up to 8 weeks (Kim et al. 2002) .
After the emergence of new and promising technologies to reprogram human fibroblasts to iPSCs (Takahashi et al. 2007; Takahashi and Yamanaka 2006) , the direct reprogramming of somatic cells to induced neurons (iNeurons) (Addis et al. 2011; Caiazzo et al. 2011; Liu et al. 2012; Oh et al. 2014) , and taking into account the positive actions of NURR1 in ESCs, this TF has been studied as a potential molecular player to obtain human DA neurons from human cells.
In one of the first studies, Theka et al. (2013) generated mature and functional DA neurons from human iPSCs (hiPSCs), derived from fetal fibroblasts and PD patients carrying a duplication in SNCA gene (that codifies for asynuclein), after being transduced with three transcription factors (ASCL1, NURR1, and LMX1A). Although, protocols for the generation of DA neurons from hiPSCs are often laborious and time-consuming, using this method, mature DA neurons were generated in 21 days, without intermediate steps that require the formation of embryoid bodies or rosette-neural precursors. The efficiency of conversion to DA neurons was higher than 93 % of the cotransduced cells and differentiated cells expressed neuronal and DA markers such as MAP2, AADC, aldehyde dehydrogenase 1 family member A1 (ALDH1A1), VMAT2, DAT, the D2R, calbindin and GIRK2. Moreover, midbrain regional markers as FOXA2, PITX3, and CORIN were also detected at least in a fraction of the DA neurons obtained. Furthermore synaptotagmin-and synapsin-positive puncta were observed along the neurites, indicating the generation of DA presynaptic contacts. Additionally, they presented spontaneous electrical activity and released dopamine. These three factors (ASCL1, NURR1, and LMX1A) showed a strong synergic effect since the transduction of each factor alone produced DA neurons having a less mature phenotype (Theka et al. 2013) .
Transduction of Nurr1 together with other factors has been used for the direct reprogramming of DA neurons from astrocytes and fibroblasts. These procedures would avoid the tumorigenic potential of DA cultures obtained from incompletely differentiated hiPSCs. However, to date the yield or efficiency of the direct reprogramming to produce DA neurons is much lower than that of using iPSCs. Direct reprogramming of astrocytes seems very interesting as it could allow in vivo neuronal generation within the adult brain. Using a polycistronic lentiviral vector containing Ascl1, Lmx1b, and Nurr1, Addis et al. (2011) differentiated mouse astrocytes into mature DA neurons. In contrast, each factor individually, did not give rise to these cells. The DA neurons obtained expressed midbrain DA markers, including TH, PITX3, LMX1A, EN1, ALDH2, FOXA2, VMAT2, Msh homeobox 1 (MSX1), DAT, and GIRK2. Moreover, they presented synaptophysin expression as well as spontaneous pacemaking activity, stimulated release of dopamine, and calcium oscillations, which are typical features of DA neurons (Addis et al. 2011) .
Finally, fibroblasts have also been directly reprogrammed into DA neurons or iNeurons (Caiazzo et al. 2011; Liu et al. 2012; Oh et al. 2014; Vierbuchen et al. 2010) . Caiazzo et al. (2011) using ASCL1, NURR1, and LMX1A were able to obtain functional DA neurons from mouse and human fibroblasts (from healthy and PD patients). Of the different combinations of TFs tested, these three factors showed a synergistic effect for the generation of induced DA neurons (iDA neurons). These cells expressed TH, VMAT2, DAT, AADC, GDNF, DRD2, ALDH1A1 and calbindin while adrenergic or serotonergic markers were not detected. Moreover, endogenous NURR1 and LMX1A were upregulated. These iDA neurons showed spontaneous pacemaking activity and released DA. However, the efficiency of conversion of adult human samples into neurons was low with 5.6 % of b-III-tubulin ? and 3.6 % of TH ? neurons. Nonetheless, when mouse iDA cells were grafted into neonatal mouse brains the cells integrated and showed extremely elaborated morphology and expression of DA markers. Moreover, they seemed to maintain neuronal excitability in vivo during 6 weeks after transplantation (Caiazzo et al. 2011) .
Other combinations of factors that include NURR1 have been used (Liu et al. 2012; Oh et al. 2014) . Liu et al. (2012) used a cocktail of lentiviral vectors containing five TFs for the direct reprogramming of human fibroblasts to DA neurons: ASCL1, NGN2, SOX2, NURR1, and PITX3. The iDA neurons obtained expressed EN1, TH, DAT, and VMAT2, produced and could uptake DA and presented DA-specific electrophysiological profiles. The overall frequency of conversion of fibroblasts to iDA neurons was also low, around 1-2 % of the plated cells. Notably, after grafting in a PD rat model, PD motor symptoms were relieved after 8 weeks post-transplantation. Furthermore, after 16 weeks transplanted cells could be observed and preserved their DA-neuron like properties in vivo (Liu et al. 2012 ). Finally Oh et al. (2014) could directly reprogram embryonic mouse fibroblasts into iNeurons using just two factors, Ascl1 and Nurr1, and the growth factors FGF8 and SHH. DA neurons were obtained with relatively high efficiency (around 16 % of the total cells) and they expressed TH and other DA markers as LMX1A, AADC, and VMAT2. The lower conversion efficiency of human cells compared to mouse ones could rely on the fact that adult human samples are usually less prone to infection than their mouse counterparts (Oh et al. 2014) .
Alternatively, other cell sources and differentiation protocols have been used to generate DA neurons (Marrelli et al. 2015; Yang et al. 2013 ). Human periapical cystmesenchymal stem cells have been efficiently differentiated towards the dopaminergic phenotype, a process that can be favored as these cells already express neural markers under basal conditions (Marrelli et al. 2015) . Moreover, the use of conditioned medium from human amniotic epithelial cells has been reported to promote human umbilical cord blood mesenchymal stem cells differentiation into DA neurons (Yang et al. 2013) . Although NURR1 over-expression was not included in these studies, using this factor together with the mentioned protocols could increase the yield of DA neuron generation from mesenchymal stem cells.
Conclusions and Future Perspectives
NURR1 has shown to be a valuable molecular player for the generation of DA neurons in vitro. This TF, implicated in the differentiation and maturation of DA neurons, their survival and maintenance, has been very useful for the optimization of the in vitro protocols used for the generation of DA neurons from different cell sources: NPCs, NSCs, and ESCs. Moreover, NURR1 is being used together with other TFs to generate DA neurons from human iPSCs, as well as for the direct conversion of astrocytes and fibroblasts into neurons. However, when Nurr1 is transduced alone, differences in the mature state of the DA neurons generated have been reported between various research groups. The co-transduction of Nurr1 with other TFs and with GDNF, has improved the yield and functionality of DA neurons, possibly as a result of a synergistic effect of NURR1 with these additional factors. The over-expression of Nurr1 in hiPSCs as a means to generate DA neurons possesses some challenges before this approach could be translated to the clinic. The tumorigenic potential of iPSCs remaining in the iPSC differentiated cultures, as well as the viral vectors employed for iPSC generation limits their potential applicability in the clinic. Nevertheless, viral vector-free methods and optimization of protocols for the purification of neural cells by cell sorting are being implemented to overcome these issues (Doi et al. 2014; Fusaki et al. 2009; Rhee et al. 2011; Warren et al. 2010; Zhou et al. 2009 ). The direct reprogramming of astrocytes or fibroblasts into DA neurons may partially elude the possibility of tumor generation after grafting. However, optimization of the efficacy of the cell conversion into DA neurons in adult human samples and the use of viral vector-free methods, as mentioned above, are required for all these techniques to be translated to the clinical practice.
